Malaysia National Medicine Policy

  • General Information

The Malaysian Ministry of Health has introduced and carried out various policies related to medicine which aims to improve the health and well-being of the people. The Malaysian National Medical Policy (MNNP) which was published in year 2007 is an official document which combines the existing and future policies together, and showcases the medium and long-term strategies for the country’s pharmaceutical sector. The policy focuses on promoting equitable access to, and rational use of safe, effective, affordable and good quality essential drugs to improve the health outcome of the people. This policy relies heavily on the coordinated effort from the public and private sectors.

In this Policy, traditional medicine is defined as “any product used in the practice of indigenous medicine, the drug consist of solely one or more naturally occurring substance of plant, animal or mineral, of parts thereof, in the unextracted or crude extract form, and homeopathic medicine (Control of Drugs and Cosmetic Regulations 1984).”

The MNMP comprises of 4 core components and 4 supportive components:-

i. QUALITY, SAFETY AND EFFICACY OF DRUGS
Policy: Only safe, efficacious and quality drugs that meet approved standards and specifications shall be registered and made available for sale and use in Malaysia.

ii. DRUG AVAILABILITY
Policy: An efficient and integrated drug management and supply network shall be maintained.

iii. DRUG AFFORDABILITY
Policy: The pharmaceutical industry shall be organized and regulated to create incentives and foster competition in drug prices. Appropriate financing mechanisms shall be developed to ensure essential drugs needed for quality healthcare are affordable.

iv. QUALITY USE OF DRUGS
Policy: Quality use of drugs by healthcare providers and consumers shall be promoted. Activities of the government, industry and media in support of informed and appropriate use of drugs by consumers shall be encouraged.

v. HUMAN RESOURCES DEVELOPMENT
Policy: The human resource needs of the pharmaceutical sector shall be planned and developed.

vi. RESEARCH AND DEVELOPMENT
Policy: Research in utilization, management and development of medicines shall be enhanced.

vii. TECHNICAL CO-OPERATION
Policy: Technical collaboration and co-operation in the implementation and strengthening of relevant areas in the pharmaceutical sector shall be established with various stakeholders at the national, regional and international levels.

viii. MANAGEMENT OF THE NATIONAL MEDICINES POLICY
Policy: All stakeholders shall be committed to the successful implementation of the National Medicines Policy.

  • Contact Details 

National Pharmaceutical Control Bureau (NPCB)
Biro Pengawalan Farmaseutikal Kebangsaan
Lot 36, Jalan Universiti
46200 Petaling Jaya,Selangor Darul Ehsan, Malaysia
Tel: +603-7883 5400
Fax: +603-7956 2924, +603-7956 7075
Website: http://www.bpfk.gov.my

Reference:

Ministry of Health Malaysia, National Medicine Policy of Malaysia. 2007. Last accessed on 7 November 2012 and available online at http://www.pharmacy.gov.my/aeimages//File/MNMP_DUNAS.pdf.